Covalon Technologies Ltd. (COV)

Currency in CAD
2.620
+0.090(+3.56%)
Closed·
COV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
COV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.5202.680
52 wk Range
2.0604.300
Key Statistics
Bid/Ask
2.54 / 2.66
Prev. Close
2.53
Open
2.52
Day's Range
2.52-2.68
52 wk Range
2.06-4.3
Volume
6.55K
Average Volume (3m)
13.6K
1-Year Change
26.57%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
COV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.750
Upside
+43.13%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Covalon Technologies Ltd. Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard brand names. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians’ offices. Covalon Technologies Ltd. was incorporated in 2004 and is headquartered in Mississauga, Canada.

Covalon Technologies Ltd. Earnings Call Summary for Q2/2025

  • Q2 2025 revenue of $7.59M missed forecast; EPS at $0.02 vs $0.03 expected; stock up 5.66% to $2.95
  • US product revenue grew with 3-year CAGR over 30%; vascular access and surgical consumables up 40% YTD
  • Cash position strong at $18M, up $11M YoY; company exploring M&A opportunities with Origin Merchant Partners
  • CEO expects sequential growth in Q3, stronger H2; plans significant expansion of ValGuard product line by 2030
  • Stock trading above Fair Value per InvestingPro; P/B ratio at 5.87x; 105.88% return over past year
Last Updated: 28/05/2025, 14:26
Read Full Transcript

Compare COV to Peers and Sector

Metrics to compare
COV
Peers
Sector
Relationship
P/E Ratio
18.8x−5.5x−0.5x
PEG Ratio
0.090.090.00
Price/Book
2.2x−2.6x2.6x
Price / LTM Sales
2.0x1.9x3.2x
Upside (Analyst Target)
48.2%235.0%40.5%
Fair Value Upside
Unlock6.5%4.4%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.750
(+43.13% Upside)

Earnings

Latest Release
May 28, 2025
EPS / Forecast
0.02 / 0.03
Revenue / Forecast
7.59M / 8.67M
EPS Revisions
Last 90 days

COV Income Statement

FAQ

What Stock Exchange Does Covalon Technologies Trade On?

Covalon Technologies is listed and trades on the TSX Venture Exchange stock exchange.

What Is the Stock Symbol for Covalon Technologies?

The stock symbol for Covalon Technologies is "COV."

What Is the Covalon Technologies Market Cap?

As of today, Covalon Technologies market cap is 70.19M.

What Is Covalon Technologies's Earnings Per Share (TTM)?

The Covalon Technologies EPS (TTM) is 0.14.

When Is the Next Covalon Technologies Earnings Date?

Covalon Technologies will release its next earnings report on 31 Aug 2025.

From a Technical Analysis Perspective, Is COV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Covalon Technologies Stock Split?

Covalon Technologies has split 1 times.

How Many Employees Does Covalon Technologies Have?

Covalon Technologies has 37 employees.

What is the current trading status of Covalon Technologies (COV)?

As of 25 Jul 2025, Covalon Technologies (COV) is trading at a price of 2.62, with a previous close of 2.53. The stock has fluctuated within a day range of 2.52 to 2.68, while its 52-week range spans from 2.06 to 4.30.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.